Skip to main content
CLB logo

Core Laboratories Inc.

CLBNYSEEnergyOil & Gas Equipment & Services

$10.22Today:- (-)1Y −42.86%

As of Oct 26, 2026 close

Market cap
$479.09M
P/E (TTM)
19.67
Forward P/E
21.90
Dividend yield
0.43%
52-week range
$9.48$20.36
Volume (live)
-
Avg. volume (3M)
642.15K

Core Laboratories (CLB) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Core Laboratories generated $37.03M of operating cash flow and spent $14.59M on capital expenditures. That left free cash flow of $22.44M, down 48.2% from $43.36M a year earlier, or 4.3% of revenue. It returned $14.29M to shareholders through $1.87M in dividends and $12.43M in share buybacks.

Core Laboratories Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Core Laboratories Inc. (CLB) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income30.3932.1537.0319.6620.22-96.9293.7179.7983.10
Depreciation & Amortization14.6514.9515.7817.1618.5220.8722.6123.0924.94
Deferred Income Tax1.420.67-10.810.436.01-12.22-36.351.839.02
Stock Based Compensation7.143.7613.977.7619.097.3920.8834.1922.94
Change in Working Capital-1.837.88-28.77-25.02-20.565.94-10.84-9.89-9.40
Change in Accounts Receivable-4.95-3.61-2.62-10.08-13.5246.42-3.192.27-18.57
Change in Inventory2.649.37-12.98-14.86-4.551.47-3.89-10.400.45
Change in Accounts Payable0.480.52-12.8815.376.57-12.84-3.76-1.758.72
Change in Other Working Capital-6.21-5.50-0.304.66-2.61-29.120.00-19.100.91
Other Operating Activities-0.62-2.35-2.414.66-0.69132.81-0.48-17.19-6.32
Net Cash from Operating Activities37.0356.3924.7924.9636.5857.8789.53111.83124.27
Investing Activities
Capital Expenditures-14.59-13.03-10.58-10.25-13.54-11.88-22.27-21.74-18.78
Acquisitions-1.240.000.000.240.871.512.98-47.310.00
Purchases of Investments0.000.000.000.0013.540.00-1.88-1.28-2.11
Sales/Maturities of Investments0.782.780.000.001.360.0022.2722.930.00
Other Investing Activities9.952.103.936.120.7318.22-6.77-23.24-18.45
Net Cash from Investing Activities-2.23-6.39-6.65-3.86-10.227.85-5.68-70.64-20.56
Financing Activities
Debt Repayment-63.00-82.00-9.00-131.00-226.00-46.0015.0064.0010.00
Common Stock Issued0.000.000.000.0060.000.000.000.000.00
Common Stock Repurchased-12.43-5.31-2.20-3.90-8.26-2.79-3.31-7.45-16.91
Dividends Paid-1.87-1.88-1.87-1.85-1.83-12.45-97.57-97.25-97.14
Other Financing Activities-1.96-0.78-5.38-2.62-1.37-1.770.01-1.77-0.03
Net Cash from Financing Activities-31.26-45.96-18.45-23.38-22.46-63.01-85.87-42.47-104.08
Summary
Net Change in Cash3.554.04-0.31-2.283.902.71-2.02-1.28-0.36
Cash at Beginning of Period19.1615.1215.4317.7013.8111.0913.1214.4014.76
Cash at End of Period22.7019.1615.1215.4317.7013.8111.0913.1214.40
Free Cash Flow22.4443.3614.2114.7123.0445.9967.2690.09105.50
Supplemental Disclosures
Interest Paid-10.8611.209.3010.48----
Income Taxes Paid-17.5814.5414.089.07----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Core Laboratories Cash Flow

What is Core Laboratories's free cash flow?

Core Laboratories generated free cash flow of $22.44M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $37.03M minus $14.59M of capital expenditures. That was down 48.2% from $43.36M a year earlier. Free cash flow equaled 4.3% of revenue.

How much does Core Laboratories spend on capital expenditures?

Core Laboratories spent $14.59M on capital expenditures in fiscal 2025, compared with $13.03M a year earlier. That equals 39.4% of operating cash flow.

Does Core Laboratories pay dividends or buy back shares?

Yes. In fiscal 2025 Core Laboratories returned $1.87M in dividends and $12.43M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition